Goldman Sachs Adds McKesson (MCK) to Conviction Buy List
Get Alerts MCK Hot Sheet
Price: $869.00 +1.44%
Rating Summary:
21 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
21 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs added McKesson (NYSE: MCK) to its Conviction Buy list with a price target of $103.
The firm sees greater upside in McKesson then AmerisourceBergen (NYSE: ABC), which was removed from the list. Upside will be driven by: sector-high growth on less headwinds and more favorable generic launch timing; contract risk that they see as manageable; discounted valuation at a PEG of 0.8X versus its historical PEG of 1.1x and peers ABC/CAH at 1.0X/1.1X despite higher growth at McKesson.
For an analyst ratings summary and ratings history on McKesson click here. For more ratings news on McKesson click here.
Shares of McKesson closed at $81.94 yesterday.
The firm sees greater upside in McKesson then AmerisourceBergen (NYSE: ABC), which was removed from the list. Upside will be driven by: sector-high growth on less headwinds and more favorable generic launch timing; contract risk that they see as manageable; discounted valuation at a PEG of 0.8X versus its historical PEG of 1.1x and peers ABC/CAH at 1.0X/1.1X despite higher growth at McKesson.
For an analyst ratings summary and ratings history on McKesson click here. For more ratings news on McKesson click here.
Shares of McKesson closed at $81.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Street Research Upgrades Micron Technology (MU) to Buy
- Ladenburg Thalmann Upgrades ONE Gas Inc. (OGS) to Buy
- Canaccord Upgrades HLS Therapeutics (HLS:CN) (HLTRF) to Buy
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Goldman Sachs Conviction Buy List, Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share